Dr Roberta Seidman, MD | |
University Hospital, Stony Brook, NY 11794-0001 | |
(631) 444-2227 | |
Not Available |
Full Name | Dr Roberta Seidman |
---|---|
Gender | Female |
Speciality | Pathology |
Experience | 41 Years |
Location | University Hospital, Stony Brook, New York |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1104869122 | NPI | - | NPPES |
01192098 | Medicaid | NY | |
78F961 | Other | NY | EMPIRE BC.BS |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZN0500X | Pathology - Neuropathology | 159602 (New York) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Suny/stony Brook University Hospital | Stony brook, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Stony Brook Pathologists, University Faculty Practice Corporation | 2163502162 | 24 |
News Archive
The COVID-19 pandemic has impacted virtually every aspect of cancer care and research- from introducing new risks for cancer patients to disrupting the delivery of cancer treatment and the continuity of cancer research, a review of scientific literature shows.
Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.
The Auxiliaries at Southern Ocean Medical Center recently announced their pledge to raise $2.5 million that will support the purchase of a TrueBeam linear accelerator, the most advanced radiation therapy technology, for the hospital. The announcement was made at Southern Ocean Medical Center Foundation's Signature Social fundraising event on July 10 at Bonnet Island Estate.
Data published in BMC Cancer and PLoS ONE show that microRNA (miRNA) biomarkers provide reliable and highly differentiated diagnosis from blood samples for lung cancer and multiple sclerosis.
› Verified 8 days ago
Entity Name | Stony Brook Pathologists, University Faculty Practice Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912944794 PECOS PAC ID: 2163502162 Enrollment ID: O20080103000301 |
News Archive
The COVID-19 pandemic has impacted virtually every aspect of cancer care and research- from introducing new risks for cancer patients to disrupting the delivery of cancer treatment and the continuity of cancer research, a review of scientific literature shows.
Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.
The Auxiliaries at Southern Ocean Medical Center recently announced their pledge to raise $2.5 million that will support the purchase of a TrueBeam linear accelerator, the most advanced radiation therapy technology, for the hospital. The announcement was made at Southern Ocean Medical Center Foundation's Signature Social fundraising event on July 10 at Bonnet Island Estate.
Data published in BMC Cancer and PLoS ONE show that microRNA (miRNA) biomarkers provide reliable and highly differentiated diagnosis from blood samples for lung cancer and multiple sclerosis.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Roberta Seidman, MD Po Box 1599, Stony Brook, NY 11790-0894 Ph: (631) 444-2227 | Dr Roberta Seidman, MD University Hospital, Stony Brook, NY 11794-0001 Ph: (631) 444-2227 |
News Archive
The COVID-19 pandemic has impacted virtually every aspect of cancer care and research- from introducing new risks for cancer patients to disrupting the delivery of cancer treatment and the continuity of cancer research, a review of scientific literature shows.
Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology's annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.
The Auxiliaries at Southern Ocean Medical Center recently announced their pledge to raise $2.5 million that will support the purchase of a TrueBeam linear accelerator, the most advanced radiation therapy technology, for the hospital. The announcement was made at Southern Ocean Medical Center Foundation's Signature Social fundraising event on July 10 at Bonnet Island Estate.
Data published in BMC Cancer and PLoS ONE show that microRNA (miRNA) biomarkers provide reliable and highly differentiated diagnosis from blood samples for lung cancer and multiple sclerosis.
› Verified 8 days ago
Maoxin Wu, M.D., PH.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: Stony Brook Pathologists Ufpc, Sbumc, Bst L9, Rm 140, Stony Brook, NY 11794 Phone: 631-444-3000 Fax: 631-444-3419 | |
Yupo Ma, MD PHD Pathology Medicare: Accepting Medicare Assignments Practice Location: Stony Brook Medical Ctr, Department Of Pathology, Stony Brook, NY 11794 Phone: 631-444-2241 Fax: 631-444-1566 | |
Dr. Eric U Yee, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 101 Nicolls Rd, Stony Brook, NY 11794 Phone: 631-444-3000 | |
Dr. Jingxuan Liu, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: University Hospital, Stony Brook, NY 11794 Phone: 631-444-2235 | |
James H Suh, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: Stony Brook University Hospital, Dept Of Pathology Hos 2, Stony Brook, NY 11794 Phone: 631-444-2224 Fax: 631-444-3424 | |
Dr. Joel H Saltz, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: Bst Level 9 Rm 140, Stony Brook, NY 11794 Phone: 631-444-3424 |